184Indexed trials
Market Rank #13 · Evidence Tier A
South Korea
Neuroscience Intelligence
South Korea neuroscience intelligence: 184 indexed trials, 102 institutions, research score 41.76.
49Recruiting
102Research institutions
41.8Research score
Evidence profile
84Sponsors
22Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 41.8 · Data confidence 100.00 · Evidence 41.8
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
alzheimers43trials
parkinsons38trials
epilepsy20trials
stroke17trials
depression9trials
autism9trials
schizophrenia8trials
neuromuscular7trials
adhd5trials
migraine_headache5trials
Leading indexed sponsors
Merck Sharp & Dohme LLC25trials
Seoul National University Hospital14trials
Hoffmann-La Roche11trials
Samsung Medical Center8trials
Eli Lilly and Company7trials
Eisai Korea Inc.5trials
GlaxoSmithKline4trials
Boehringer Ingelheim4trials
Pfizer4trials
Yonsei University4trials